Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Sept 2026 for Neurocrine Biosciences INC, €311k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Matthew C Abernethy: trading record in brief
One trade, one date: on 14 September 2026, Matthew C Abernethy disclosed a transaction of €311k in Neurocrine Biosciences Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew C Abernethy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
2,311 shares@ US$156.22CommonSEC144:0001950047-26-009441
1 of 1 declaration
